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Summary
Regulatory T cell-mediated dominant tolerance has
been demonstrated to play an important role in the
prevention of autoimmunity. Here, we present data ar-
guing that the forkhead transcription factor Foxp3
acts as the regulatory T cell lineage specification
factor and mediator of the genetic mechanism of do-
minant tolerance. We show that expression of Foxp3
is highly restricted to the subset  of T cells and,
irrespective of CD25 expression, correlates with sup-
pressor activity. Induction of Foxp3 expression in
nonregulatory T cells does not occur during patho-
gen-driven immune responses, and Foxp3 deficiency
does not impact the functional responses of nonregu-
latory T cells. Furthermore, T cell-specific ablation of
Foxp3 is sufficient to induce the identical early onset
lymphoproliferative syndrome observed in Foxp3-
deficient mice. Analysis of Foxp3 expression during
thymic development suggests that this mechanism is
not hard-wired but is dependent on TCR/MHC ligand
interactions.
Introduction
Despite a large body of evidence demonstrating the
functional properties of regulatory T cells (TR) (Shevach,
2002), an unambiguous molecular definition of this cell
type and its mechanism of action have yet to be real-
ized. Due in large part to this problem, the very exis-
tence of T cells dedicated to maintaining self-tolerance
was the source of great controversy until recently. A
major breakthrough in the field came when a subset of
CD4+ T cells constitutively expressing the high-affinity
IL-2 receptor alpha chain (CD25) was found to be highly
enriched for immunosuppressive activity (Sakaguchi et
al., 1995). While other molecules have been suggested
to identify unique TR cell populations, only the
CD4+CD25+ TR cell population has been consistently
shown to display suppressive properties across spe-
cies and in multiple disease models. Consistent with a
role for these cells in maintaining self-tolerance, anti-
body depletion of CD25+ cells in mice or reconstitution
of lymphopenic mice with CD25− T cells results in the
development of slowly progressing autoimmune inflam-*Correspondence: fontenot@u.washington.edu (J.D.F.); aruden@
u.washington.edu (A.Y.R.)mation in multiple organs. Nevertheless, the value of
CD25 as a marker of the TR cell population is limited.
CD25 is highly expressed on both activated CD4+ and
CD8+ T cells, obviating its utility in studying TR cells in
settings of immune activation.
The X chromosome-encoded forkhead transcription
factor, Foxp3, was recently identified as a key player in
CD4+CD25+ TR cell biology. Unlike CD25, CTLA-4,
GITR, and LAG-3 (markers proposed to define the TR
cell population), Foxp3 is not upregulated in recently
activated CD4+CD25− T cells. Consistent with a funda-
mental breakdown in self-tolerance, mice genetically
deficient in Foxp3 succumb to a rapid and fatal lym-
phoproliferative autoimmune syndrome at 3–4 weeks of
age (Brunkow et al., 2001; Fontenot et al., 2003; God-
frey et al., 1991). Moreover, Foxp3-deficient mice fail to
generate a CD4+CD25+ TR cell population (Fontenot et
al., 2003). Ectopic expression of Foxp3 in nonregulatory
T cells has been demonstrated to confer suppressor
activity (Fontenot et al., 2003; Hori et al., 2003; Khattri
et al., 2003). However, in these studies, only a subset
of the Foxp3-expressing cells upregulated CD25 ex-
pression and acquired suppressor function after 2
weeks in vivo (Fontenot et al., 2003). Similarly, only
those cells expressing the highest levels of Foxp3 ac-
quired elevated levels of CD25 and were shown to pos-
sess suppressor activity in vitro (Hori et al., 2003). To-
gether, these studies suggest that CD25 expression
correlates more closely with suppressor activity than
Foxp3 expression. Foxp3 has also been implicated in
the cell intrinsic negative regulation of CD4+ T cell acti-
vation (Clark et al., 1999; Khattri et al., 2001; Schubert
et al., 2001). Furthermore, low levels of Foxp3 expres-
sion have been reported in CD4+CD25− and CD8+ T
cells as well as in B220+ cells (Brunkow et al., 2001;
Fontenot et al., 2003; Hori et al., 2003) implying an as
yet uncharacterized role in other hematopoeitc lin-
eages. Thus, the role of Foxp3 in the hematopoietic
system and the relationship between Foxp3, CD25 ex-
pression, and the TR cell population has remained un-
defined.
The lack of an unambiguous molecular definition of
TR cells has severely hampered efforts to experimen-
tally address the developmental processes that gen-
erate these cells and their functional role within the
immune system. Given the much more aggressive auto-
immune syndrome resulting from genetic deficiency in
Foxp3 as compared to that resulting from CD25+ T cell
depletion, we hypothesized that Foxp3 expression
would identify a TR cell population beyond that defined
by CD25 expression. Furthermore, we hypothesized
that Foxp3 acts to establish and maintain a TR cell ge-
netic program and would thus be a definitive marker of
the TR cell population. To address these hypotheses,
we have generated mice harboring a GFP-Foxp3 fusion
protein-reporter knockin allele. Analysis of Foxp3gfp
mice demonstrates that Foxp3 expression identifies the
TR cell population. Our results argue that Foxp3 func-
tions as the TR cell lineage specification factor and me-
diator of the genetic mechanism of dominant tolerance.
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T
Generation and Characterization
of the Foxp3gfp Allele v
aTo facilitate the analysis of Foxp3 expression at the sin-
gle-cell level, we generated gene-targeted mice in p
twhich the complete eGFP coding sequence was in-
serted in-frame into the first coding exon of the Foxp3 t
Cgene (Figures 1A and 1B and Figure S1; see the Supple-
mental Data available with this article online). The re- a
Fsulting allele (Foxp3gfp) encodes a chimeric GFP-Foxp3
fusion protein (Foxp3gfp), having eGFP inserted down- r
(stream of the first five N-terminal amino acids of Foxp3
and upstream of the entire remaining Foxp3 molecule v
m(Figure 1C).
Only a single Foxp3 allele is active in a given female c
Ccell due to random X chromosome inactivation (Schu-
bert et al., 2001), and only a single allele is present in r
tmale cells. Thus, to be useful in studying the function
of Foxp3, it was incumbent that the Foxp3gfp allele t
mfaithfully recapitulate Foxp3 function. Consistent with
this, male mice hemizygous for the Foxp3gfp allele and r
bhomozygous Foxp3gfp/gfp female mice remained as
healthy as their wild-type (wt) littermates throughout t
pthe period of observation (up to 9 months). Initial FACS
analysis of Foxp3gfp mice revealed a small, discrete s
gpopulation of GFP-expressing cells, confirming expres-
sion of the Foxp3gfp allele (Figure 2A). Consistent with r
the nuclear localization of Foxp3, examination of indivi-
dual GFP+ cells with deconvolution microscopy re-
vealed GFP expression almost exclusively within the F
Tnucleus (Figure 2B). FACS analysis showed thatFigure 1. The Foxp3gfp Allele
(A) Maps of the targeting construct and targeted Foxp3gfp allele. Asterisks denote the location of external probes used for a Southern blot
screen of ES cell clone DNA digested with the indicated restriction endonucleases. Black triangles denote oligonucleotide primers for PCR
genotyping of the targeted allele.
(B) Enlarged view of the first coding exon of the Foxp3gfp allele with the amino acid translation of the open reading frame below. The red
“ATG” denotes the endogenous Foxp3 start codon. The green sequence denotes the eGFP-coding sequence.
(C) Scale diagram of the Foxp3gfp chimeric protein.Foxp3gfp and Foxp3wt mice had equivalent percentagesf all major lymphoid populations examined, including
cells and thymocytes (Figure S1).
Since, Foxp3 has been implicated in the thymic de-
elopment of CD4+CD25+ TR cells, we next focused our
nalysis on this population. Foxp3gfp mice had normal
ercentages of CD4+CD25+ T cells (Figure 2C), and
hese cells expressed characteristic patterns of mul-
iple cell surface markers, including CTLA-4, GITR, and
D103 (Figure S1). Furthermore, in vitro functional
nalysis demonstrated that CD4+CD25+ TR cells from
oxp3gfp and Foxp3wt mice suppressed the proliferative
esponse of wt CD4+CD25− T cells with equal potency
Figure 2D). To test the competitive fitness of Foxp3gfp
ersus Foxp3wt CD4+CD25+ TR cells, we analyzed fe-
ale mice heterozygous for the Foxp3gfp allele. Be-
ause Foxp3 is required for development of the
D4+CD25+ TR cell population (Fontenot et al., 2003),
andom X chromosome inactivation predicts a 50:50 ra-
io of CD4+CD25+ T cells expressing either allele. Al-
hough there was significant variability from mouse to
ouse, analysis of both CD4+ SP thymocytes and pe-
ipheral CD4+ T cells revealed an average ratio of w1
etween the proportions of GFP+ to GFP− cells within
he CD4+CD25+ T cell population (Figure 2E). These
opulations expressed identical patterns of the cell
urface markers analyzed above (data not shown). To-
ether, these results argue that the Foxp3gfp allele fully
ecapitulates Foxp3 function.
oxp3 Expression Identifies the TR Cell Population
o gain insight into the biological function of Foxp3through its cell type-specific expression pattern, we an-
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331Figure 2. The Foxp3gfp Allele Fully Recapitulates Wild-Type Foxp3 Function
(A) Expression of Foxp3gfp in lymphocytes from Foxp3gfp mice. Flow cytometric analysis of live gated lymph node cells from male littermates
of the indicated genotype.
(B) Nuclear localization of Foxp3gfp. Typical single-cell profile of purified CD4+CD25+ T cells from a Foxp3gfp mouse that were counterstained
with DAPI and analyzed by deconvolution microscopy.
(C) Analysis of CD4+CD25+ T cell subsets in Foxp3gfp and Foxp3wt mice. Flow cytometric analysis of live gated lymph node cells from littermate
male mice of the indicated genotype.
(D) Comparable suppressor function of Foxp3gfp and Foxp3wt CD4+CD25+ T cells. An in vitro suppression assay was performed by using Con
A stimulation of cocultures of 2 × 104 wt CD4+CD25− T cells as responders, 8 × 104 irradiated TCRbd−/− splenocytes as APCs, and titrated
numbers of CD4+CD25+ T cells from littermate male mice of the indicated genotype as suppressors. Data are presented as mean cpm 3H-
thymidine incorporation in triplicate cultures. Error bars indicate standard deviation of the mean.
(E) Analysis of Foxp3gfp and Foxp3wt CD4+CD25+ T cell subsets in female heterozygous Foxp3gfp/wt mice. Representative FACS analysis of
CD4+ cell gated lymph node cells from a female Foxp3gfp/wt mouse. The box plots show the average GFP+/GFP− ratio among CD4+CD25+
cells as gated accompanying FACS plot from thymus and lymph node within the same animal (n = 10). Error bars indicate standard deviation
of the mean.alyzed Foxp3gfp expression within the major hemato-
poietic lineages. Foxp3gfp expression is highly restricted
(>99.8%) to TCRβ+ cells (Figure 3A). Lack of Foxp3gfp
expression in TCRγδ+ and NK1.1+ populations, which
include both NK and NKT cells, further demonstrates
that Foxp3 expression is limited to αβ T cells. No
Foxp3gfp expression was observed in other hematopoi-
etic lineages, including B cells, macrophages, and den-
dritic cells, either in unmanipulated mice or upon in vi-
tro activation with immunostimulatory molecules
including LPS, CpG DNA, and zymosan (data not
shown). Consistent with these observations, FACS
analysis of splenocytes, lymph node cells, and thymo-
cytes from RAG1−/− Foxp3gfp mice, which lack all T and
B cells, revealed a complete loss of Foxp3gfp-express-
ing cells (Figure 3B and data not shown). Furthermore,
αβ T cell-restricted expression of Foxp3 was main-
tained after infection of Foxp3gfp mice with Listeria
monocytogenes (L.m.), LCMV, or Mycobacterium tuber-
culosis (M.tb.) (data not shown). Thus, we concludethat, within the hematopoietic lineage, Foxp3 is uniquely
expressed in αβ T cells. To determine if Foxp3 was ex-
pressed in other nonhematopoietic cell types or tis-
sues, we conducted immunohistochemical analysis of
tissues from RAG1−/− Foxp3gfp mice. Remarkably, no
Foxp3 expression was detected in the thymus, second-
ary lymphoid organs, or nonlymphoid tissues, including
brain, lung, liver, skin, and testes (data not shown).
Among lymph node cells, Foxp3 expression was
largely restricted to CD4+ T cells (>97% of Foxp3gfp+
cells are CD4+CD8−), but small populations of Foxp3-
expressing TCRβ+ cells expressed CD8, both CD4 and
CD8 (DP), or neither CD4 nor CD8 (DN) (Figure 3C). No
significant difference in Foxp3gfp levels were observed
among these four populations (data not shown). Distri-
bution of Foxp3gfp+ T cells among the CD4/CD8 pop-
ulations was similar in the lymph nodes, spleen, periph-
eral blood, bone marrow, and peripheral tissues, e.g.,
lung (data not shown). Since CD25 has been used as a
marker for TR cells, we next examined CD25 expression
Immunity
332Figure 3. Foxp3 Expression Is Restricted to a Subset of αβ T Cells
(A) Foxp3 expression is restricted to TCRβ+ cells. Flow cytometric analysis of Foxp3gfp expression in live gated lymph node cells.
(B) Foxp3-expressing cells are lost in RAG-deficient mice. Flow cytometric analysis of live gated spleen cells from RAG1−/− mice of the
indicated genotype.
(C) CD4 and CD8 expression among Foxp3-expressing cells. Flow cytometric analysis of lymph node cells from Foxp3gfp mice; plot is gated
on Foxp3gfp+ live cells.
(D) CD4 and CD25 expression among Foxp3-expressing cells. Representative flow cytometric analysis of Foxp3gfp+ cells from the indicated
organ; cells within the live Foxp3gfp+ gate are shown.
(E) Foxp3 and CD25 expression in the CD4+ T cell population. Flow cytometric analysis of lymph node cells within the live CD4+ gate
are shown.Fwithin the total Foxp3gfp+ population. In healthy 6- to 8-
Fweek-old micew82% of lymph node Foxp3-expressing
tcells were CD4+CD25hi (Figure 3D). In the spleen the per-
pcentage of CD4+CD25hi Foxp3gfp+ T cells dropped to
ew60% of Foxp3gfp+ cells. Remarkably, less than 50%
cof Foxp3gfp+ lymphocytes isolated from PBS-perfused
plung expressed high levels of CD25. Thus, Foxp3gfp ex-
epression is largely restricted to CD4+ T cells, and a sig-
lnificant percentage of Foxp3gfp+ T cells express little or
no CD25.
To address the relationship between Foxp3 and CD25 G
expression and TR cell function, we next focused our T
analysis on the total CD4+ T cell population. This pop-
T
ulation includes the vast majority (>97%) of Foxp3- f
expressing cells. Analysis of CD4+ T cells revealed four e
populations: the CD25−Foxp3gfp− “naive” T cell subset, a
a population of CD25+Foxp3gfp− cells, CD25hiFoxp3gfp+ 4
cells, and a Foxp3gfp+ population expressing little or no r
CD25 (CD25loFoxp3gfp+) (Figure 3E). The presence of C
both Foxp3gfp+ and Foxp3gfp− CD25-expressing pop- e
ulations allowed us to directly address the relationship o
between CD25 expression and TR cell function. To this c
end, the four indicated subpopulations of CD4+ T cells p
(Figure 4A) were purified to >90% purity by using a l
combination of magnetic cell separation and FACS C
sorting. Functional analysis revealed that both popula- t
tions of Foxp3gfp+ CD4+ T cells were unresponsive to C
stimulation with ConA and APCs in vitro (Figure 4C). In n
contrast, the CD4+CD25+Foxp3gfp− cells proliferated to i
a much greater extent than either the CD4+CD25−oxp3gfp− or CD4+ cells depleted of all Foxp3gfp+ cells.
inally, in vitro suppression assays revealed that both
he CD4+CD25hiFoxp3gfp+ and CD4+CD25loFoxp3gfp+
opulations suppressed CD4+ T cell proliferation with
qual potency, while neither the CD4+CD25−Foxp3gfp−
ells nor the CD4+CD25+Foxp3gfp− cells showed sup-
ressor activity (Figure 4D). We conclude that Foxp3
xpression, and not CD25 expression, directly corre-
ates with TR cell function.
ene Expression Profiling of CD4
Cell Subpopulations
o gain insight into the transcriptional program speci-
ied by Foxp3 expression, we interrogated the mRNA
xpression profiles of the four CD4+ T cell subsets
s defined by Foxp3gfp and CD25 expression (Figure
A) by using Affymetrix Mouse Genome 430 2.0 ar-
ays. Normalized expression values from the “naive”
D4+CD25−Foxp3gfp− population were used as a refer-
nce for pairwise comparison with values from each
f the three “non-naive” populations. Genes with fold-
hanges meeting stringent selection criteria (see Ex-
erimental Procedures) were chosen, and these gene
ists were analyzed for similarities and differences.
omparisons of the overlapping gene sets reveal that
he two Foxp3-expressing populations (CD25hi versus
D25lo) share a largely common gene expression sig-
ature, whereas the CD25+Foxp3gfp− population exhib-
ted little overlap with either of the Foxp3gfp+ popula-
tions (Figure 4E). In addition to very high levels of Foxp3
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333mRNA, both Foxp3gfp+ cell subsets displayed increased
expression of IL-10, CD103, Klrg1, Nrp1, GITR, ICOS,
Fgl2, Gpr83, and CTLA-4 and decreased expression of
FasL, Sema4a, IL-4, Pde3b, and Pde7a (Figure 4F)—a
gene expression pattern highly characteristic of TR
cells (Gavin et al., 2002; McHugh et al., 2002). These
data demonstrate that both the CD25hi and CD25lo
populations share a TR cell gene expression profile and
argue that Foxp3 expression specifies this transcrip-
tional program.
Examination of the overlaps among these subpopu-
lations reveals several other distinct gene expression
patterns (Figure 4F). First, data sets from all three “non-
naive” populations share genes characteristic of acti-
vated lymphocytes (e.g., increased expression of OX40,
CD44, IL2Rα/β, and hexokinase). Second, the CD25+
Foxp3gfp− cells show a gene expression profile charac-
teristic of activated/effector T cells (increased expres-
sion of IL-2, IL-4, IL-17, T-bet, and Edg3, and decreased
CD62L expression). FACS analysis of the CD25+
Foxp3gfp− population corroborates this analysis, show-
ing a significant enrichment of cells with an activated
phenotype—expressing high levels of CD69 and de-
creased levels of CD62L and CD45RB (Figure 4A). Fi-
nally, comparison of gene expression levels between
the CD25lo and CD25hi Foxp3-expressing populations
suggests that the CD25loFoxp3gfp+ population may be
enriched for effector or tissue-homing cells (Figure 4F).
Relative to the CD25hi population, the CD25loFoxp3gfp+
cells have increased expression of ICOS, CCR2,
CXCR3, CCR5, and β1-integrin. Again, FACS analysis
reveals that this population is enriched for cells ex-
pressing high levels of CD69 and decreased levels of
CD62L and CD45RB (Figure 4A). Consistent with these
data, this subset is also significantly enriched for pro-
liferating cells expressing Ki67, a cell cycle-associ-
ated nuclear protein (Figure 4B). These data are also
in agreement with the enrichment of CD4+CD25lo
Foxp3gfp+ T cells in the lungs of both uninfected and
chronically M.tb.-infected mice (Figure 3C and data
not shown).
No Cell Intrinsic Role for Foxp3 in Effector
T Cell Function
The data presented thus far support the hypothesis
that Foxp3 acts as the TR cell lineage specification
factor. However, increased proliferation and cytokine
secretion by CD4+ T cells isolated from Foxp3-deficient
scurfy mice has led to the proposal that Foxp3 may
also act as a cell-intrinsic negative regulator of CD4+
T cell activation and inflammatory cytokine production
(Clark et al., 1999; Khattri et al., 2001; Schubert et al.,
2001). It has also been suggested that Foxp3-deficient
CD4+ T cells exhibit a decreased dependence on CD28-
mediated costimulation (Clark et al., 1999). In fact, the
ongoing lymphoproliferative syndrome in these mice
complicates these conclusions. We sought to directly
test whether Foxp3 deficiency can affect the dose de-
pendence of, or costimulation requirements for, anti-
gen-specific responses of naive nonregulatory CD4+ T
cells. To this end, we bred the Foxp3− allele onto OT-II
TCR transgenic RAG1−/− mice. As reported, restricting
the TCR repertoire to a single specificity for a known
foreign antigen (in this case the ovalbumin 323–339peptide, Ova) rescues Foxp3-deficient mice from the
lymphoproliferative autoimmune syndrome (Zahorsky-
Reeves and Wilkinson, 2001). OT-II RAG1−/−Foxp3−
mice were healthy and phenotypically indistinguishable
from their OT-II RAG1−/−Foxp3+ littermates. Absolute
numbers and relative percentages of thymocyte and
peripheral T cell subpopulations in OT-II RAG1−/−
Foxp3− and OT-II RAG1−/−Foxp3+ littermates were iden-
tical based upon expression of CD4, CD8, TCR, and a
panel of additional cell surface markers (Figure S2). We
conclude that Foxp3 deficiency does not impact the
development of nonregulatory CD4+ T cells. Impor-
tantly, mature T cells from OT-II RAG1−/−Foxp3− mice
showed no evidence of activation based upon expres-
sion levels of CD69, CD25, and CD62L (Figure S2). In
this situation, we were able to directly compare the ef-
fect of Foxp3 deficiency on naive CD4+ T cell function.
OT-II RAG1−/− CD4+ T cells from Foxp3− and Foxp3+
mice mounted identical proliferative response to tit-
rated amounts of the cognate Ova peptide in the pres-
ence of wt APCs and similarly diminished responses
in the presence of costimulation-deficient APCs from
CD80/CD86 double knockout mice (Figure 5A). These
results argue that Foxp3 deficiency does not impact
the antigen sensitivity, costimulation requirement, or
proliferative capacity of nonregulatory CD4+ T cells.
To address the role of Foxp3 in a polyclonal nonregu-
latory T cell population exposed to more physiological
immune stimuli, i.e. infection, we generated mixed bone
marrow chimeras by transferring Foxp3− CD45.1− and
Foxp3+ CD45.1+ congenic bone marrow into sublethally
irradiated TCRbd-deficient recipient mice. As in hetero-
zygous Foxp3+/− female mice, the presence of Foxp3+
bone marrow-derived cells rescues the lymphoprolifer-
ative autoimmune syndrome (Fontenot et al., 2003). In
this setting, functional responses of naive T cells de-
rived from Foxp3+ and Foxp3− bone marrow, as distin-
guished by expression of CD45.1, can be directly
tested in the same mouse. Mixed bone marrow chim-
eric mice were infected with LCMV or ovalbumin-
expressing L.m. (rLmOva) 8−12 weeks post-bone mar-
row reconstitution, and antigen-specific responses of
both CD4+ and CD8+ T cells were assessed on day 7
and 8 postinfection by measuring intracellular cytokine
production in response to in vitro restimulation with
MHC class I- and MHC class II-restricted antigenic
peptides. Prior to infection, peripheral blood was ana-
lyzed by flow cytometry to determine the relative contri-
bution of the Foxp3− CD45.1− and Foxp3+ CD45.1+
bone marrow to the total T cell pool in each mouse.
After infection with either LCMV or rLmOva, the relative
percentages of Foxp3+ and Foxp3− T cells remained
constant. Furthermore, upon in vitro restimulation,
Foxp3− and Fopx3+ CD4+ T cells (Figures 5B and 5C)
and CD8+ T cells (data not shown) produced IL-2, TNF-α,
and IFN-γ with the same frequency and at the same
levels on a per cell basis. Together, these data argue
against a cell-intrinsic role for Foxp3 in regulating the
expansion and cytokine production of nonregulatory T
cells.
“Adaptive” Foxp3-Expressing TR Cells Are Not
Generated De Novo in the Course
of Acute Immune Responses
Early studies suggested that antigen-driven differentia-
tion of precursor T cells may result in de novo genera-
Immunity
334Figure 4. TR Cell Phenotype and Function Correlates with Foxp3 Expression
(A) Flow cytometric analysis of Foxp3/CD25-expressing subpopulations of lymph node CD4+ cells. Histograms are shown for cells from each
of the subpopulations as indicated in the first FACS plot (left panel) and correspond to the gated population of the same color and position
in the first plot (CD25loFoxp3gfp+, blue; CD25hiFoxp3gfp+, green; CD25+Foxp3gfp−, red; CD25−Foxp3gfp−, black).
(B) Flow cytometric identification of proliferating Ki67+ cells within Foxp3/CD25-expressing subpopulations of lymph node CD4+ T cells.
Color-coded gates for four cell subsets are the same as above.
(C) In vitro proliferative responses of the indicated purified Foxp3/CD25-expressing CD4+ T cell subpopulations (1 × 104 cells/well) from
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335lated on mature SP thymocytes after transition from theunique function for Foxp3 within this cell type. This fact
Foxp3gfp mice cultured in the presence of Con A and irradiated TCRbd−/− splenocytes (4 × 104 cells/well) as APCs. (CD25loFoxp3gfp+, blue;
CD25hiFoxp3gfp+, green; CD25+Foxp3gfp−, red; CD25−Foxp3gfp−, black; see Figure 4D legend). A representative of three experiments is shown.
(D) Foxp3 expression defines regulatory T cells within both CD25hi and CD25lo CD4 T cell subsets. An in vitro suppression assay was
performed by using Con A stimulation of cocultures of 1 × 104 Foxp3gfp− T cells as responders, 4 × 104 irradiated TCRbd −/− splenocytes as
APCs, and titrated numbers of indicated populations of purified Foxp3/CD25-expressing CD4+ T cells from Foxp3gfp mice as suppressors
starting at a 1 × 104 cells/well. Data in (C) and (D) are presented as mean cpm 3H-thymidine incorporation in triplicate cultures. Error bars
indicate standard deviation of the mean.
(E and F) Comparison of gene expression profiles between four subsets of Foxp3/CD25-expressing CD4+ T cells from Foxp3gfp mice. (E)
Overlap among gene lists generated by microarray expression profiling of each of the four FACS-sorted, Foxp3/CD25-expressing CD4+
subpopulations described above. Differentially expressed genes were selected by comparing each of the indicated populations against the
CD4+CD25−Foxp3gfp− population as described in the Experimental Procedures. The Venn diagram illustrates the number of genes shared
between the three lists. (F) Curated heatmaps of distinct expression profiles revealed by microarray analysis of the four Foxp3/CD25 CD4+
subpopulations. The genes for the first heatmap were selected from the 228 overlapping genes between the two Foxp3-expressing popula-
tions; for the second heatmap, genes were selected from the 267 genes unique to the CD25+ Foxp3gfp− population; and for the third heatmap,
genes were selected from the 133 genes differentially expressed by all three non-naive populations. Colors indicate log2 fold-change versus
the baseline CD25−Foxp3gfp− population. The rightmost panel illustrates differences in the mRNA expression profiles of the two Foxp3-
expressing populations. For all four panels, genes were selected from the gene sets indicated in Figure 4E.tion of antigen-specific suppressor T cells (Tandon et
al., 1979). This would imply that a dominant suppres-
sion mechanism, i.e., Foxp3, is induced as feedback
regulation to limit conventional antigen-specific im-
mune responses. To address this issue, CD4+Foxp3gfp−
T cells from OT-II TCR transgenic Foxp3gfp mice were
FACS sorted to >99.8% purity and stimulated either in
vitro in the presence of the Ova peptide and irradiated
APCs, or in vivo by adoptive transfer into unirradiated
CD45.1+ congenic recipients followed by infection
with rLmOva.
FACS analysis of OT-II CD4+ T cells activated in vitro
by titrated amounts of Ova peptide for various periods
from 12 hr to 7 days revealed no detectable Foxp3
upregulation at any time point (Figure 5D and data not
shown). Similarly, no Foxp3 expression was detected in
adoptively transferred OT-II CD4+ T cells 7 days postin-
fection with rLmOva (Figure 5D). In these experiments,
antigen-specific activation of the adoptively transferred
OT-II Foxp3gfp T cells was confirmed by their expansion
and cell surface expression of characteristic activation
markers (CD25, CD69, CD62L) in rLmOva-infected, but
not in wt L.m.-infected or uninfected recipient mice
(Figure 5D and data not shown). These data do not rule
out the possibility that under certain conditions some T
cells can upregulate Foxp3. However, our experiments
demonstrate that de novo generation of “adaptive” TR
cells by Foxp3 induction in nonregulatory T cells does
not occur in the course of acute pathogen-driven im-
mune responses.
T Cell-Specific Ablation of Foxp3
The dramatic difference in the phenotype of Foxp3-
deficient mice when compared to mice depleted of
CD25+ cells (McHugh and Shevach, 2002; Taguchi and
Takahashi, 1996) or lymphopenic mice reconstituted
with CD25− T cells (Sakaguchi et al., 1995) suggested
that Foxp3 may have immunoregulatory functions out-
side the T cell compartment or, perhaps, the hemato-
poietic system. While the lymphoproliferative autoim-
munity observed in Foxp3-deficient mice can be
ameliorated in the short term by neonatal transfer of
CD4+CD25+ TR cells (Fontenot et al., 2003), this result
only demonstrates the remarkable immunosuppressive
potential of CD4+CD25+ TR cells, but does not prove ais highlighted by the ability of CD4+CD25+ TR cells
to suppress immune pathology not resulting from
CD4+CD25+ TR cell defects such as in allograft trans-
plantation (Wood and Sakaguchi, 2003). Although we
have not observed expression of Foxp3 in non-T cells,
this negative result does not exclude the possibility that
a deficiency in Foxp3 expression in other cell types
may contribute to the aggressive lymphoproliferative
syndrome of Foxp3-deficient mice.
To directly resolve this major outstanding issue, we
generated mice in which Foxp3 was deleted specifi-
cally in αβ T cells by crossing mice harboring a loxP-
flanked Foxp3 allele (Fontenot et al., 2003) to CD4-Cre
transgenic mice (Wolfer et al., 2001). Consistent with a
unique role for Foxp3 in T cells, male CD4-Cre Foxp3lox
mice develop the outward symptoms of Foxp3 defi-
ciency, including runting and severe exfoliative derma-
titis with the exact same kinetics and severity as
age-matched Foxp3− mice. At day 14 of age, lympho-
proliferation, as evidenced by total lymph node cellular-
ity, was equivalent in CD4-Cre Foxp3lox and Foxp3−
mice (Figure 6A). Furthermore, CD4+ T cells from mice
of both genotypes contained equivalent proportions of
cells expressing a panel of activation markers, includ-
ing CD69, CD62L, CD25, and CD44 (Figure 6B). Thus,
T cell-specific ablation of Foxp3 results in a lympho-
proliferative autoimmune syndrome identical to that ob-
served in Foxp3− mice.
TCR/MHC Interactions Drive TR Cell Development
The signals driving TR cell development in the thymus
have not been defined. The data presented thus far ar-
gue that Foxp3 functions as the lineage specification
factor for TR cells. Thus, understanding the signals that
induce Foxp3 expression in the thymus should illumi-
nate the process by which this cell fate choice is made.
Analysis of the Foxp3gfp+ thymocytes revealed that
Foxp3 expression was largely restricted to CD4 SP thy-
mocytes (w83% of Foxp3gfp+ thymocytes) (Figure 7A).
However, minor populations of CD8 SP, DP, and DN
cells were also evident. These populations of Foxp3gfp+
cells expressed equivalent levels of TCR (data not
shown). To assess the maturation stage of Foxp3-
expressing thymocytes, we analyzed CD24, or heat-
stable antigen (HSA), expression. CD24 is downregu-
Immunity
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(A) Foxp3 deficiency does not affect proliferative responses of naive CD4+ T cells. Proliferative responses of 2 × 104 CD4+ T cells from OT-II
RAG1−/−Foxp3− or Foxp3+ mice to titrated amounts of Ova peptide in the presence of 4 × 104 irradiated CD11c+ Flt3L-induced wt or
CD80−/−CD86−/− dendritic cells. Data are presented as mean cpm 3H-thymidine incorporation in triplicate cultures. Error bars indicate standard
deviation of the mean.
(B and C) Comparable cytokine production by pathogen-specific Foxp3+ (CD45.1+) or Foxp3− (CD45.1−) CD4+ T cells from mixed bone marrow
chimeras. Intracellular staining for indicated cytokines after (B) in vitro restimulation with LLO190-201 peptide of splenocytes isolated from
mice 7 days after rLmOva infection and (C) in vitro restimulation with GP66 peptide of splenocytes isolated from mice 8 days after LCMV
infection. Representative FACS plots of three or more mice per group are gated on CD4+ T cells. One of two similar experiments is shown.
(D) Lack of antigen-driven Foxp3 upregulation in nonregulatory CD4+ T cells upon antigenic challenge in vitro and in vivo. The leftmost panel
shows representative flow cytometric analysis of Foxp3gfp−CD4+ T cells sorted from OT-II Foxp3gfp mice prior to activation in vitro or in vivo.
The panel second from the left shows analysis of transferred T cells on day 7 of in vitro activation in the presence of CD45.1+ dendritic cells
and Ova peptide. The last three panels show transferred T cells 8 days after infection of CD45.1+ host mice with indicated pathogen. Mice
were infected 2 days after i.v. transfer of purified T cells. The gates for donor CD45.1− cells are shown.DP stage. Analysis of the CD24loFoxp3gfp+ population
trevealed a substantial decrease in the percentage of
Foxp3gfp+DPhi cells but no significant change in CD4 i
wSP, CD8 SP, DPdull, or DN populations when compared
to total Foxp3gfp+ cells (Figures 7A and 7B). Consistent (
bwith the low level of CD24 expression by the majority
of Foxp3-expressing thymocytes, immunohistochemi- b
dcal analysis revealed that the majority of Foxp3gfp+ cells
are found in the thymic medulla, the site known to har- o
wbor the most mature thymocyte population (Figure 7C).
The few Foxp3gfp+ cells within the thymic cortex were g
iin proximity to the cortico-medullary junction.To more clearly delineate the relationship between
hymic populations of Foxp3-expressing cells and to
nvestigate a role for TCR signaling in Foxp3 induction,
e crossed Foxp3gfp mice on to MHC class I-deficient
b2M−/−), MHC class II-deficient (Abb −/−), and dou-
le-deficient backgrounds (b2M−/−Abb −/−). Analysis of
2M−/−Foxp3gfp mice clearly demonstrates the depen-
ence of the DPdull and CD8 SP Foxp3gfp+ populations
n MHC class I expression (Figures 7A and 7B). Like-
ise, development of the CD4 SP population is contin-
ent upon MHC class II expression. No compensatory
ncrease in the absolute numbers of CD8 SP Foxp3gfp+
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337Figure 6. T Cell-Specific Deletion of Foxp3
Recapitulates the Lymphoproliferative Auto-
immune Syndrome of Germline Foxp3-Defi-
cient Mice
(A) Lymph node cellularity of 14-day-old wt,
Foxp3−, and CD4-Cre Foxp3lox mice and
photographs of lymph nodes and spleen
from these mice.
(B) Expression of activation markers on
CD4+ T cells in 14-day-old wt, Foxp3−, and
CD4-Cre Foxp3lox mice. Representative flow
cytometric data gated on CD4+ TCRβ+ cells
are shown.also been shown to confer suppressor activity on some pression is not limited to CD4 CD25 T cells. This im-
Figure 7. Thymic Development of Foxp3+ TR Cells
(A) MHC class I- and MHC class II-restricted Foxp3-expressing thymocyte populations. Flow cytometric analysis of Foxp3gfp+ thymocytes
from Foxp3gfp mice on wt and MHC-deficient backgrounds. Plots are gated on total Foxp3gfp+ live cells from Foxp3gfp mice of the indicated ge-
notypes.
(B) Flow cytometric analysis of mature CD24loFoxp3gfp+ thymocyte subsets from Foxp3gfp mice on wt and MHC-deficient back-
grounds.
(C) Localization of Foxp3-expressing TR cell precursors within the thymus. A representative immunostained thymic section from a Foxp3gfp
mouse is shown; Foxp3gfp+ thymocytes (αGFP, green); thymic cortex (αBP-1, blue); thymic medulla (mAb 3G10, red).thymocytes was observed in MHC class II-deficient
mice relative to wt mice (data not shown). Remarkably,
Foxp3 expression was completely lost in all thymo-
cytes, including expression in both the DN and imma-
ture CD24hi DP populations, in b2M−/−Abb −/− double-
deficient mice. These results identify both MHC class
I- and MHC class II-restricted populations of Foxp3-
expressing T cells developing in the thymus. Further-
more, they demonstrate that Foxp3 expression is in-
dependent of commitment to either the CD4 or CD8
lineage but strictly dependent on TCR/MHC interac-
tions.
Discussion
We have recently demonstrated that Foxp3 is required
for the thymic development of CD4+CD25+ TR cells
(Fontenot et al., 2003). Ectopic expression of Foxp3 hasnonregulatory T cells (Fontenot et al., 2003; Hori et al.,
2003; Khattri et al., 2003). While these data clearly de-
monstrate that Foxp3 has a critical role in CD4+CD25+
TR cell biology, it was unclear if this role was sufficient
to explain the phenotype associated with Foxp3 defi-
ciency. Foxp3 has been suggested to function as a
negative regulator of T cell activation and, perhaps, as
a transcriptional “effector” of an anti-inflammatory cy-
tokine program (Clark et al., 1999; Khattri et al., 2001;
Schubert et al., 2001). Thus, a reasonable hypothesis
was that Foxp3 may play a common role in multiple cell
types both within and, perhaps, outside the immune
system to regulate immune activation and inflamma-
tion. Together, these roles could explain the aggressive
life-threatening lymphoproliferation resulting from Foxp3
deficiency in both humans and mice. An alternative hy-
pothesis would envision a unique role for Foxp3 in TR
cell lineage specification. In this scenario, Foxp3 ex-
+ +
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Floss of the TR cell lineage and loss of the genetic mech-
anism of dominant tolerance. g
t
CFoxp3 as the TR Cell Lineage Specification Factor
Our studies demonstrate that Foxp3 expression in αβ T p
cells, irrespective of CD25 expression, correlates with (
suppressor activity. Foxp3 expression is limited to a T
small subset of αβ T cells in both naive and pathogen- s
challenged animals. Moreover, Foxp3 deficiency does c
not impact the functional responses of nonregulatory T s
cells to biologically relevant antigens, i.e. pathogens, (
and induction of Foxp3 expression in nonregulatory T s
cells does not appear to be part of a pathogen-induced m
mechanism for limiting immune responses in vivo. We I
also show that Foxp3-expressing CD4+ T cells share a T
common gene expression profile. While we have not p
been able to test the suppressive properties of the mi- t
nor CD8+, CD4+CD8+, and CD4−CD8− Foxp3+ T cell v
subsets due to very limited cell numbers, elevated cell F
surface expression of CD25, CTLA-4, and GITR on t
these cells is consistent with these cells having similar p
functional properties as CD4+Foxp3+ T cells (Figure S3). o
Thus, we believe that the preponderance of evidence o
is consistent with all Foxp3-expressing cells being part F
of the TR cell population. In aggregate, these data ar- i
gue that Foxp3 functions as the TR cell lineage specifi- n
cation factor.
The remarkably restricted expression of Foxp3 to a
subset of αβ T cells, as revealed in our analysis, is A
Whighly unusual for a transcription factor and suggests
a recent evolutionary origin. Although a role for Foxp3 F
ain nonhematopoietic cells has been suggested to con-
tribute to the aggressive lymphoproliferative syndrome t
cobserved in Foxp3-deficient mice, we have found no
evidence of Foxp3 expression in nonhematopoietic tis- a
Fsues. More importantly, it is clear that T cell-specific
deletion of Foxp3 is sufficient to induce the identical C
Flymphoproliferative syndrome observed in mice with
germline Foxp3 deficiency. This result establishes a vi- p
ntal role for Foxp3-expressing TR cells in the mainte-
nance of dominant tolerance to self. Moreover, it un- o
sequivocally demonstrates a deficiency in TR cells as the
cause of the fatal IPEX autoimmune syndrome in hu- c
smans and its correlate in mice.
i
CCD25loFoxp3+ Regulatory T Cells m
Our analysis of the total CD4 population of the Foxp3gfp
mice revealed two intriguing populations: regulatory
CD4+CD25loFoxp3gfp+ T cells and activated/effector S
iCD4+CD25+Foxp3gfp− T cells. The nature of the regula-
tory CD4+CD25loFoxp3gfp+ T cell population is of partic- W
Tular interest. The importance of this population is un-
derscored by the fact that these cells comprise greater m
ethan 50% of the tissue-infiltrating, Foxp3-expressing T
cell population in the lungs of both uninfected and t
aM.tb.-infected Foxp3gfp mice. These data highlight the
limitations of using CD25 as a marker for TR cells. Nota- c
Cbly, the CD4+CD25loFoxp3gfp+ T cell population is en-
riched for cells with an activated surface pheno- a
vtype and for proliferating cells. Consistent with these
findings, comparisons of the transcriptional profiles Af CD4+CD25loFoxp3gfp+ T cells and CD4+CD25hi
oxp3gfp+ T cells showed upregulation of a number of
enes responsible for regulatory effector function or
issue migration such as ICOS, IL-10, CCR2, CXCR3,
CR5, and β1-integrin in the CD25lo population.
Despite low surface levels of CD25, these cells ex-
ress elevated levels of both CD25 (IL-2Rα) and CD122
IL-2Rβ) mRNA, albeit lower than CD4+CD25hiFoxp3gfp+
cells. It is likely that a portion of these cells has tran-
iently downregulated CD25 upon proliferation, as de-
reased levels of CD25 on TR cells undergoing homeo-
tatic proliferation have been previously reported
Gavin et al., 2002). CD25 downregulation may also re-
ult from trafficking to areas where IL-2 is limiting, as
aintenance of CD25 expression in Foxp3+ TR cells is
L-2 dependent (J.D.F. and A.Y.R., unpublished data).
he increase in this population in the secondary lym-
hoid organs and peripheral tissues is consistent with
his phenotype developing in the periphery upon acti-
ation or upon IL-2 deprivation of CD4+CD25hi
oxp3gfp+ T cells. Importantly, our data demonstrate
hat CD4+CD25loFoxp3gfp+ T cells maintain potent sup-
ressive activity. Consistent with these results, analysis
f CD4+ T cells from the lung and draining lymph node
f M.tb.-infected mice demonstrate that only the
oxp3gfp−, but none of the Foxp3gfp+ cells, produce pro-
nflammatory cytokines such as TNF-α or IFN-γ (data
ot shown).
ctivated/Effector CD4+CD25+Foxp3− T Cells
e have also identified a population of CD4+CD25+
oxp3gfp− T cells. These cells are highly enriched for
ctivated/effector cells as suggested by their transcrip-
ional profile demonstrating upregulation of cytokine or
ytokine regulation-related genes (e.g., IL-2, IL-4, T-bet),
s well as genes related to cell cycle and apoptosis.
ACS analysis confirmed the activated phenotype of
D4+CD25+Foxp3gfp− T cells. Furthermore, CD4+CD25+
oxp3gfp− T cells exhibit a remarkably high proliferative
otential in vitro and were significantly increased in
umbers in the spleen, draining lymph nodes, and lung
f M.tb.-infected mice (data not shown). These results
uggest that, in normal mice, this subset contains T
ells responding to microbial or autoantigens. These re-
ults again highlight the utility of Foxp3 in distinguish-
ng TR from the activated/effector cells within the
D25+ T cell population, especially in settings of im-
une activation.
ignals Required for Induction of Foxp3
n the Thymus
hat are the signals that induce Foxp3 expression and
R cell lineage commitment? In agreement with their
ature phenotype, we find the vast majority of Foxp3-
xpressing thymocytes localized to the medulla, with
he remaining Foxp3+ cells located in the deep cortex,
djacent to the cortico-medullary junction. These latter
ells most likely correspond to the subset of immature
D24hiFoxp3gfp+ DP thymocytes. Foxp3-expressing SP
nd DP subsets appear concurrently during mouse de-
elopment and in fetal thymic organ culture (J.D.F. and
.Y.R., unpublished data). Thus, we find no evidence
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339for a precursor-product relationship between the
CD24hiFoxp3gfp+ DP population and the CD24lo
Foxp3gfp+ populations. Furthermore, the highly diverse
TCR repertoire of the CD4+CD25+ TR cell population ar-
gues against such a scenario (Hsieh et al., 2004; Taka-
hashi et al., 1998).
Our analysis of MHC-deficient (b2M−/−Abb −/−) Foxp3gfp
mice demonstrates that TCR/MHC interactions are re-
quired for induction of Foxp3 expression. We observed
Foxp3 expression in immature CD24hi DP thymocytes
in MHC class I-deficient, and MHC class II-deficient, as
well as wt backgrounds and an absolute MHC depen-
dence for Foxp3 upregulation in these populations.
These data argue that Foxp3 expression does not re-
quire transition to the SP stage and that DP thymocytes
rely on TCR interactions with either MHC class I or
MHC class II for Foxp3 induction. These observations
are consistent with an instructive role for TCR signaling
in induction of Foxp3 expression and, therefore, TR cell
development. Furthermore, these data rule out a
stochastic/selective model in which DP thymocytes
randomly upregulate Foxp3 prior to positive selection,
since this model predicts the presence of Foxp3-
expressing DP thymocytes in a MHC-deficient setting.
The unexpected presence of both MHC class I- and
MHC class II-restricted Foxp3-expressing cell popula-
tions also demonstrates that Foxp3 expression does
not depend on specific CD4 or CD8 lineage choice.
However, the fact that the great majority of Foxp3-
expressing thymocytes are MHC class II-restricted CD4
SP suggests that the signals driving the CD4/CD8 lin-
eage choice may also be linked to Foxp3 induction.
One possible explanation for the prevalence of Foxp3-
expressing CD4 SP is offered by the view that CD4 lin-
eage commitment requires a TCR signal of a greater
strength or extended duration than that needed for CD8
lineage commitment (Bosselut, 2004). Notably, recent
studies from our lab suggest that a large number of
CD25+CD4+ TR cells express TCRs with an increased
avidity for self-peptide-MHC complexes (Hsieh et al.,
2004). Together with observations that coexpression of
transgenes encoding a TCR and its cognate ligand can
promote the development of CD4+CD25+ TR cells
(Apostolou et al., 2002; Jordan et al., 2001), these re-
sults argue that the TCR avidity of the bulk of TR cells
is likely to fall within the grey area between positive and
negative selection, and would allow for stronger and/or
more persistent TCR signal resulting in the prevalent
development of CD4 lineage cells expressing Foxp3.
In conclusion, data presented herein argue that
Foxp3 acts as the TR cell lineage specification factor
and mediator of the genetic mechanism of dominant
tolerance. Based on these data, we propose that Foxp3
expression defines the TR cell lineage. The fatal autoim-
mune disease observed in mice with T cell-specific ab-
lation of Foxp3 demonstrates TR cell-mediated domi-
nant tolerance to be a vital mechanism of immune
homeostasis. We suggest that the need for such a dedi-
cated mechanism was driven by the emergence of MHC-
restricted recognition by T cells and the associated
developmental requirements for reactivity with self-
peptide-MHC complexes. The early onset of the lym-
phoproliferative syndrome in mice deficient in Foxp3,and thus TR cells, suggests that this mechanism
evolved to control T cell self-reactivity and autoimmune
inflammation. As a consequence of this function, TR
cells cause downmodulation of chronic inflammation
associated with other types of immune responses while
not specifically developing to limit pathogen-specific
responses. Finally, the absolute dependence of Foxp3
expression on TCR-peptide-MHC interactions in the
thymus strongly argues that dominant tolerance is not
a hard-wired, but an induced, mechanism of negative
feedback regulation to maintain immune homeostasis
through recognition of molecular self.
Experimental Procedures
Mice
Mice were housed under specific pathogen-free conditions and
used according to the guidelines of the Institutional Animal Care
Committee at the University of Washington. Generation of the
Foxp3gfp allele is described in Figure S1. Foxp3− and Foxp3lox were
previously described (Fontenot et al., 2003). C57BL/6, B6.SJL-
Ptprca Pep3b/BoyJ, and C57BL/6J-Rag1tm1Mom and TCRβδ−/− mice
were from the Jackson Laboratory (Bar Harbor, ME). Additional pre-
viously described mouse lines used in these studies include: OT-II
TCR, CD4-Cre, b2M−/−, Abb−/−, and CD80−/−CD86−/. All mice were
used at the age of 6–12 weeks unless specified in the text.
Antibodies, FACS Analysis, and Cell Sorting
Conjugated antibodies were purchased from both BD Pharmingen
(San Jose, CA) and eBioscience (San Diego, CA). FACS analysis
was preformed by using FACSCalibur and LSR II flow cytometers
(Becton Dickinson, Palo Alto, CA) and were analyzed with FlowJo
software.
For analysis of CD4+CD25 × Foxp3gfp subsets, CD4+ T cells were
enriched prior to FACS sorting by depletion of total lymph node
and spleen cell suspension with a cocktail of biotinylated antibod-
ies specific for CD8, B220, CD11b, NK1.1, and DX5, followed by
anti-biotin MACS beads. The remaining cells were labeled with
CD4-PerCP antibodies, CD25-APC antibodies, and PE-conjugated
streptavidin. CD4+PE− cells were sorted into four populations
based on expression of GFP and CD25 as indicated in Figure 5 to
greater than 90% purity. All cell sorting was performed by using
the FACSAria cell sorter.
T Cell Functional Assays
Proliferation and suppression assays were preformed as de-
scribed, with modifications as indicated in the figure legends (Fon-
tenot et al., 2003). In Figure 2, suppressor cells were MACS purified
by using PC61 antibody. In some experiments, OT-II T cells were
stimulated with titrated amounts of ovalbumin 323–339 peptide in
the presence of irradiated, MACS-purified, CD11c+ FLT3L-induced
dendritic cells prepared as described (Mach et al., 2000). All data
are shown as mean [3H]thymidine incorporation in triplicate cul-
tures. Error bars indicate standard deviation of the mean.
For analysis of pathogen-specific immune responses, infections,
T cell stimulation, and intracellular cytokine staining of splenic T
cell populations isolated from Lm-, rLmOva-, or LCMV-infected
mice were conducted as previously described (Tyznik et al., 2004).
Microarray Sample Preparation and Analysis
Total RNA was isolated by using the RNeasy Mini Kit (Qiagen). Bio-
tinylated antisense cRNA was prepared by using two cycles of
in vitro amplification according to the Affymetrix Small Sample La-
beling Protocol II. 15 g biotinylated cRNA was fragmented and
hybridized to Affymetrix GeneChip Mouse Genome 430 2.0 arrays
at the Stanford PAN Facility (Palo Alto, CA).
All data analyses were performed by using Bioconductor version
1.5 (Gentleman et al., 2004) for the statistical software R (http://
www.r-project.org). Expression values were background corrected,
Immunity
340normalized, and summarized by using the default settings of the G
gcrma package (Wu et al., 2004). As these values exhibited inten- D
sity-dependent variation, we used a sliding intensity window to se- c
lect differentially expressed genes for each pairwise comparison. a
Within each slice along the intensity scale, probe sets with a fold-
Gchange R 2.57 standard deviations away from the local mean and
la minimum average log2 average intensity value of 4 were selected.
tHeatmaps were generated by hand curation of these gene lists.
H
TMicroscopy and Immunohistochemistry
1For single-cell imaging, purified CD4+CD25+ T cells were fixed with
H4% paraformaldehyde in PBS prior to deposition on poly-L-lysine-
scoated slides by cytospin. Direct GFP fluorescence and DAPI
counterstain were imaged with an API-Delta Vision deconvolution i
microscopy system. Thymic sections were prepared and stained J
as described (Lehar et al., 2004) with rabbit anti-GFP antibody, di- A
goxigenin-conjugated mAb 3G10, and Alexa-647-conjugated anti-
t
BP1(6C3); followed by Alexa 546-conjugated goat anti-rabbit IgG,
p
anti-digoxigenin-fluorescein; followed by Alexa 488-conjugated
Krabbit anti-fluorescein. Images were acquired with a Leica SP1/MP
Bconfocal microscope.
o
s
KSupplemental Data
eSupplemental Data including four supplemental figures are avail-
mable at http://www.immunity.com/cgi/content/full/22/3/329/DC1/.
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